Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06851325 · ClinicalTrials.gov registry record
Antiplatelets and Intramyocardial Hemorrhage in STEMI: Incidence and Outcomes
A clinical trial of Acute Myocardial Infarction and STEMI, sponsored by Rohan Dharmakumar.
- Completed
- Registry status
- 6,180
- Enrollment target
- 1
- Study location
NCT06851325 is a study of Acute Myocardial Infarction and STEMI that has completed, run by Rohan Dharmakumar. The registered enrollment target is 6,180 participants, above the 1,557-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (297% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06851325, a study of Acute Myocardial Infarction and STEMI, has completed, sponsored by Rohan Dharmakumar.
- COMPLETED
- Registry status
- 6,180 participants
- Enrollment target
- 1
- Study location
Study Summary
The MIRON-PLATELET study is a retrospective, observational multi-center analysis assessing the impact of different antiplatelet therapies on hemorrhagic myocardial infarction (HMI) incidence and outcomes in STEMI patients. Key endpoints include hemorrhagic transformation, MACE, bleeding complications, and 30-day mortality. Findings will offer insights into the safety and clinical implications of antiplatelet therapy in high-risk patients.
Conditions Studied
Study Locations (1)
Indiana
- Medical Imaging Research Institute - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,180 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2025-02-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06851325
The ClinicalTrials.gov registry entry for NCT06851325 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6,180 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,557-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (297% higher). The listed sponsor is Rohan Dharmakumar, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.
NCT06851325 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT06851325 about?
NCT06851325 is a clinical study titled "Antiplatelets and Intramyocardial Hemorrhage in STEMI: Incidence and Outcomes". The MIRON-PLATELET study is a retrospective, observational multi-center analysis assessing the impact of different antiplatelet therapies on hemorrhagic myocardial infarction (HMI) incidence and outcomes in STEMI patients. Key endpoints include hemorrhagic transformation, MACE, bleeding complication...
What is the current status of trial NCT06851325?
This trial is currently completed. The enrollment target is 6,180 participants. The study started on 2023-05-01. Estimated completion is 2025-02-11.
What conditions does trial NCT06851325 study?
This clinical trial studies the following conditions: Acute Myocardial Infarction, STEMI.
Who is sponsoring clinical trial NCT06851325?
This trial is sponsored by Rohan Dharmakumar, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06851325 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
RECRUITING · NA
-
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
RECRUITING
-
Abbott Vascular Medical Device Registry
RECRUITING
-
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
RECRUITING · NA
-
Arrhythmia Detection After MI
RECRUITING · NA
-
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.